Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;34(10):2557-2576.
doi: 10.1002/ptr.6704. Epub 2020 Apr 19.

Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma

Mahsa Salehi  1 , Ahmad Movahedpour  2   3 , Alireza Tayarani  4 , Zahra Shabaninejad  5   6 , Mohammad H Pourhanifeh  7 , Erfan Mortezapour  8 , Ali Nickdasti  8 , Reza Mottaghi  9 , Abdolhossein Davoodabadi  10 , Haroon Khan  11 , Amir Savardashtaki  2   6 , Hamed Mirzaei  8
Affiliations
Review

Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma

Mahsa Salehi et al. Phytother Res. 2020 Oct.

Abstract

Non-small-cell lung carcinoma (NSCLC) is one of the most lethal malignancies that include more than 80% of lung cancer cases worldwide. During the past decades, plants and plant-derived products have attracted great interest in the treatment of various human diseases. Curcumin, the turmeric isolated natural phenolic compound, has shown a promising chemo-preventive and anticancer agent. Numerous studies have shown that curcumin delays the initiation and progression of NSCLC by affecting a wide range of molecular targets and cell signalling pathways including NF-kB, Akt, MAPKS, BCL-2, ROS and microRNAs (miRNAs). However, the poor oral bioavailability and low chemical stability of curcumin remain as major challenges in the utilisation of this compound as a therapeutic agent. Different analogs of curcumin and new delivery systems (e.g., micelles, nanoparticles and liposomes) provided promising solutions to overcome these obstacles and improve curcumin pharmacokinetic profile. The present review focuses on current reported studies about anti-NSCLC effects of curcumin. NSCLC involved miRNAs whose expression is regulated by curcumin has also been discussed. Furthermore, recent researches on the use of curcumin analogs and delivery systems to enhance the curcumin benefits in NSCLC are also described.

Keywords: Curcumin; non-small cell lung cancer (NSCLC); therapy.

PubMed Disclaimer

References

REFERENCES

    1. Aggarwal, B. B., & Harikumar, K. B. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The International Journal of Biochemistry & Cell Biology, 41(1), 40-59.
    1. Ak, T., & Gulcin, I. (2008). Antioxidant and radical scavenging properties of curcumin. Chemico-Biological Interactions, 174(1), 27-37.
    1. Alexandrow, M. G., Song, L. J., Altiok, S., Gray, J., Haura, E. B., & Kumar, N. B. (2012). Curcumin: A novel Stat3 pathway inhibitor for chemoprevention of lung cancer. European Journal of Cancer Prevention, 21(5), 407-412.
    1. Amin, S., & Khan, H. (2016). Revival of natural products: Utilization of modern technologies. Current Bioactive Compounds, 12(2), 103-106.
    1. Andjelkovic, T., Pesic, M., Bankovic, J., Tanic, N., Markovic, I. D., & Ruzdijic, S. (2008). Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R). Cancer Biology & Therapy, 7(7), 1024-1032.

MeSH terms

LinkOut - more resources